Groton, CT, United States of America

Knicholaus Dudley La Lumiere



 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Knicholaus Dudley La Lumiere: Innovator in Pharmaceutical Synthesis

Introduction

Knicholaus Dudley La Lumiere is an accomplished inventor based in Groton, Connecticut, known for his innovative contributions to the field of pharmaceutical synthesis. With a focus on improving the manufacturing processes of medications, La Lumiere's research has led to advancements that are both efficient and effective.

Latest Patents

La Lumiere holds a patent for the "Low-temperature synthesis of methylphenidate hydrochloride." This invention outlines a novel process for preparing methylphenidate hydrochloride, which involves the esterification of ritalinic acid and methanol using an acid catalyst at low temperatures. The process may also include the optional addition of an orthoester, making it a significant advancement in the synthesis of this important pharmaceutical compound.

Career Highlights

Currently, La Lumiere is associated with Rhodes Technologies, where he continues to engage in impactful research and development. His work contributes to the company’s mission of improving the quality and accessibility of pharmaceutical products. His innovation is recognized for not only its technical merit but also its potential to enhance drug production efficiency.

Collaborations

Throughout his career, La Lumiere has collaborated with notable peers, including C. Frederick M. Huntley and Erik Wayne Kataisto. These collaborations have fostered a dynamic environment for innovation and have played a crucial role in the development of new methods and compounds in pharmaceutical manufacturing.

Conclusion

Knicholaus Dudley La Lumiere exemplifies the spirit of innovation within the pharmaceutical industry. His patented method for synthesizing methylphenidate hydrochloride reflects a commitment to advancing drug manufacturing processes while demonstrating the importance of collaborative efforts in achieving significant scientific breakthroughs. As the landscape of pharmaceutical development continues to evolve, La Lumiere's contributions will undoubtedly play a role in shaping the future of medication synthesis.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…